Literature DB >> 32241250

Correction to: Expressive language sampling as a source of outcome measures for treatment studies in fragile X syndrome: feasibility, practice effects, test-retest reliability, and construct validity.

Leonard Abbeduto1, Elizabeth Berry-Kravis2, Audra Sterling3, Stephanie Sherman4, Jamie O Edgin5, Andrea McDuffie6, Anne Hoffmann2, Debra Hamilton4, Michael Nelson2, Jeannie Aschkenasy2, Angela John Thurman6.   

Abstract

In the original publication of this article [1], the author name Leonard Abbeduto was misspelled as Leonardkk Abbeduto. The original article has been corrected.

Entities:  

Year:  2020        PMID： 32241250      PMCID： PMC7119274          DOI： 10.1186/s11689-020-09314-5

Source DB:  PubMed          Journal:  J Neurodev Disord        ISSN： 1866-1947            Impact factor:   4.025


  1 in total

1.  Expressive language sampling as a source of outcome measures for treatment studies in fragile X syndrome: feasibility, practice effects, test-retest reliability, and construct validity.

Authors:  Leonard Abbeduto; Elizabeth Berry-Kravis; Audra Sterling; Stephanie Sherman; Jamie O Edgin; Andrea McDuffie; Anne Hoffmann; Debra Hamilton; Michael Nelson; Jeannie Aschkenasy; Angela John Thurman
Journal:  J Neurodev Disord       Date:  2020-03-24       Impact factor: 4.025
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.